2017--2018学年人教版必修四Unit 4 Body language Using language课时作业 (2)
2017--2018学年人教版必修四Unit 4 Body language Using language课时作业 (2)第1页

Unit 4 Body language Using language课时作业

Ⅰ.阅读理解

  阅读下列短文,从每题所给的四个选项(A、B、C和D)中选出最佳选项。

(原创)A new study shows a vaccine designed to prevent dengue fever(登革热)could actually be making people sick. Dengue infects an estimated 400 million people worldwide each year. The virus spreads to human beings through the bite of an insect, the mosquito.

Most people who get dengue suffer health problems like those resulting from a mild case of influenza, like a higher than normal body temperature. But the illness is more severe the second time a person gets it. In serious cases, it can cause bleeding inside the body and even death. About 25,000 people a year die from the infection.

The drug Dengvaxia is so far the only vaccine approved for use against dengue. Several countries - including Brazil, Mexico, Costa Rica, Paraguay and the Philippines - have already approved use of the drug.

Trials of Dengvaxia involved more than 30,000 people in 10 countries. Among young people, the drug was found to reduce infections by 60 percent, and hospitalizations by 80 percent. But over time, many of those vaccinated got seriously ill with dengue.

Researchers from Britain and the United States studied the results of the tests. They found the vaccine acted as a first infection in people who had not had the virus before. The researchers reported their findings in the journal Science. They say they are concerned that people who get infected a second time after the vaccine can get severely sick.

The study found that the vaccine should not be a problem in countries with many cases of dengue. In such areas, Dengvaxia was found to reduce severe sickness and hospitalizations by 20 percent to 30 percent. But the researchers warned that in countries where only 10 percent of people have been infected with dengue, the vaccine needs to be carefully used. Ideally, Rodriguez­Barraquer said, people should be tested before getting vaccinated, to see if they have been infected in the past.

1. How many countries have approved the use of Dengvaxia?

A. Three.         B. Four.

C. Five. D. Six.

2. What's the problem of the drug Dengvaxia?

A. Children who are vaccinated will have a high fever.

B. It doesn't work on young people when vaccinated for the first time.

C. People who get infected a second time after the vaccine can get severely sick.

D. It can not be given to anyone younger than twelve years old.

3. From the last paragraph we can infer ________.

A. the vaccine can be used in areas with serious dengue

B. anyone who wants to get vaccinated must be tested first